Cozaar and Tetrabenazine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported only by a few people who take Cozaar and Tetrabenazine together.

The phase IV clinical study analyzes what interactions people who take Cozaar and Tetrabenazine have. It is created by eHealthMe based on reports of 4 people who take the same drugs from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Mar, 28, 2023

4 people who take Cozaar and Tetrabenazine together, and have interactions are studied.


What is Cozaar?

Cozaar has active ingredients of losartan potassium. It is often used in high blood pressure. eHealthMe is studying from 43,284 Cozaar users for its effectiveness, alternative drugs and more.

What is Tetrabenazine?

Tetrabenazine has active ingredients of tetrabenazine. eHealthMe is studying from 1,393 Tetrabenazine users for its effectiveness, alternative drugs and more.

Number of Cozaar and Tetrabenazine reports submitted per year:

Cozaar and Tetrabenazine drug interactions.

Common Cozaar and Tetrabenazine drug interactions by gender *:

female:

  1. Pharyngitis
  2. Platelet count increased
  3. Post procedural complication
  4. Protein total increased
  5. Rash macular
  6. Red blood cell count decreased
  7. Red blood cell sedimentation rate increased
  8. Renal disorder
  9. Resting tremor
  10. Restless legs syndrome

male:

  1. Cerebral ventricle dilatation
  2. Choking
  3. Movement disorder
  4. Muscular weakness
  5. Nuclear magnetic resonance imaging brain
  6. Parkinsonism
  7. Post procedural complication
  8. Rash macular
  9. Renal failure acute
  10. Renal tubular necrosis

Common Cozaar and Tetrabenazine drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Dyskinesia
  2. Extrapyramidal disorder
  3. Cerebral ventricle dilatation
  4. Choking
  5. Cholelithiasis
  6. Choreoathetosis
  7. Colonic polyp
  8. Coronary artery disease
  9. Coronary artery restenosis
  10. Depression

50-59:

n/a

60+:

n/a

* Approximation only. Some reports may have incomplete information.

Do you take Cozaar and Tetrabenazine?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related publications that referenced our studies

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Cozaar and Tetrabenazine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Cozaar side effects:

Browse all side effects of Cozaar:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Tetrabenazine side effects:

Browse all side effects of Tetrabenazine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Cozaar interactions:

Browse all interactions between Cozaar and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Tetrabenazine interactions:

Browse all interactions between Tetrabenazine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on losartan potassium and tetrabenazine (the active ingredients of Cozaar and Tetrabenazine, respectively), and Cozaar and Tetrabenazine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Cozaar and Tetrabenazine.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: